Marcello Damiani

[Moderna @moderna_tx]

Moderna’s Sr Director of Informatics, Dave Johnson, discusses how #AI frees up time for our researchers to focus on science. Learn more about 3 top AI #healthcare opportunities & Moderna’s commitment to #digital from @BusinessInsider: 

https://t.co/g77lnO25dO

[McKinsey & Company @McKinsey]

A new breed of #biotechnology firms, unencumbered by the accumulated practices and systems of large traditional ones, are pioneering impressive new #digital capabilities. https://t.co/oVYu1a36fb

[Moderna @moderna_tx]

Thrilled to be opening our new manufacturing facility in Norwood, MA today. The new site enables us to more efficiently advance our pipeline of potential mRNA medicines. Learn more: https://t.co/24SOiM1wEf

[Moderna @moderna_tx]

Our partner @AstraZeneca details how mRNA-based medicines can be used as a potential regenerative treatment for #heartfailure: https://t.co/m9XI4YlXe8

[Marcus Borba @marcusborba]

#SAPPHIRENOW experts from industry discusssing how to build Intelligent Enterprises to gain competitive advantage

@mdidonato1 @beyondtechs @marcellodami @AnthoulaN @shell

#ArtificialIntelligence #MachineLearning #IntelligentEnterprise

[Mark Smith @MarkSmithISG]

Learning about the journey to Intelligent Enterprise with @Sap at #SAPPHIRENOW with @mdidonato1 @marcellodami @anthoulam @beyondtechs

[Michelle Schooff @MichelleSchooff]

To digitally transform, start with a full blueprint to remove inefficiencies within your business. @marcellodami @moderna_tx @SAPPHIRENOW @SAPIndustries @CMacken2

[Michelle Schooff @MichelleSchooff]

“From day 1 we have been focused on data and now use Artificial Intelligence to analyze that data at Moderna Therapeutics.” @marcellodami @SAPIndustries @SAPPHIRENOW #LifeSciences @CMacken2

[Marcello Damiani @marcellodami]

https://t.co/1amwNrXW9Q

[Marcello Damiani @marcellodami]

we just opened this position, if you know of anyone interested please share ! https://t.co/5LYBLQ6LxU

[Moderna @moderna_tx]

New Moderna paper in @MolTherapy describes the science behind the first example of using lipid nanoparticles to repeat dose #mRNA in non-human primates safely -- and at therapeutically relevant levels.
https://t.co/9f5Lhn6PKL

[Moderna @moderna_tx]

Pre-clinical data published today in Cell Reports supports our first rare liver disease development program, an #mRNA therapeutic for Methylmalonic Acidemia (MMA). @cellreports @NIH https://t.co/hwSLeORqEA

[Moderna @moderna_tx]

Check out this great case study explaining how @awscloud is a fundamental component of Moderna’s digital strategy – powering our #mRNA R&D and manufacturing processes. https://t.co/t0iT8n52Wf

[Moderna @moderna_tx]

Today marks a key milestone in our collaboration with @Merck as we work together to advance #mRNA personalized #CancerVaccines in combination with immune-stimulatory cancer therapies to help more patients respond to treatment.

[Moderna @moderna_tx]

We are pleased to announce that we have started dosing patients in a Phase 1 study (KEYNOTE-603) of our #mRNA personalized #CancerVaccine – mRNA-4157. https://t.co/L9TMrhvC9C

[Moderna @moderna_tx]

Moderna & @AstraZeneca to advance new development candidate AZD7970, a Relaxin #mRNA tx to address serious unmet need in heart failure.

[Moderna @moderna_tx]

In new blog post, our Chief HR Officer Annie Drapeau reflects on passion & commitment of the Moderna team https://t.co/bDW8Ti1TXu

[Marcello Damiani @marcellodami]

Secrets of bacterial antibiotic resistance unravelled, paving way for new life-saving drugs https://t.co/SsbjJ14g9K

[Moderna @moderna_tx]

So proud of the progress our team is making on behalf of patients. Filed an IND for our 10th #mRNA medicine in less than two years!

[Boomi @boomi]

.@moderna_tx accelerates, scales #biotech innovation with #cloudintegration. https://t.co/xthqDXubJQ